Xiaoqin Li

Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development

Angelo Aguilar, Jianfeng Lü, Liu Liu et al. · Journal of Medicinal Chemistry · 2017 · 203 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Attributable causes of colorectal cancer in China

Mengjia Gu, Q. Huang, Chengzhen Bao et al. · BMC Cancer · 2018 · 159 citations · Full text

Medicine, Oncology, Preventive Medicine +15

Expression of MRP1, BCRP, LRP, and ERCC1 in Advanced Non–Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and Survival

Jian Li, Zhennan Li, Yong-Jie Du et al. · Clinical Lung Cancer · 2009 · 69 citations

Medicine, Cancer Biology, Oncology +6

Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy

Jian Li, Zhennan Li, Lichao Yu et al. · Lung Cancer · 2009 · 68 citations

Medicine, Oncology, Chemotherapy +7

RETRACTED: CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway

Mengyao Sun, Sujuan Wang, Xiaoqin Li et al. · Frontiers in Pharmacology · 2019 · 67 citations · Full text

Medicine, Molecular Biology, Nephrology +17